4D Molecular Therapeutics, Inc.
FDMT
$10.45
$0.111.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.61% | -5.23% | -39.22% | -45.89% | -38.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 30.04% | 4.22% | -17.50% | -5.85% | 14.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.89% | -5.01% | -38.84% | -45.12% | -37.91% |
|
|
|||||
| Total Current Assets | 21.89% | -5.01% | -38.84% | -45.12% | -37.91% |
| Net Property, Plant & Equipment | -20.89% | -18.71% | -15.78% | 26.16% | 27.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.97% | 115.63% | 227.51% | 304.74% | 813.49% |
| Total Assets | -0.55% | 1.13% | -29.81% | -23.62% | -18.12% |
|
|
|||||
| Total Accounts Payable | 253.94% | 154.42% | 134.71% | 153.57% | -1.57% |
| Total Accrued Expenses | 41.12% | 42.42% | 12.95% | 50.20% | 79.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.40% | -0.80% | 11.86% | 79.01% | 78.98% |
| Total Finance Division Other Current Liabilities | -58.43% | 40.08% | 928.57% | -- | -- |
| Total Other Current Liabilities | -58.43% | 40.08% | 928.57% | -- | -- |
| Total Current Liabilities | 61.36% | 50.90% | 25.94% | 78.72% | 63.99% |
|
|
|||||
| Total Current Liabilities | 61.36% | 50.90% | 25.94% | 78.72% | 63.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.19% | -16.60% | -16.08% | 65.93% | 65.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 180.39% | -25.24% | -29.27% | -62.70% | -51.46% |
| Total Liabilities | 32.74% | 22.64% | 7.67% | 65.99% | 56.89% |
|
|
|||||
| Common Stock & APIC | 13.12% | 12.39% | 2.38% | 2.62% | 4.31% |
| Retained Earnings | -25.78% | -24.32% | -39.73% | -40.64% | -39.41% |
| Treasury Stock & Other | -154.22% | 217.47% | -37.81% | 215.02% | 404.59% |
| Total Common Equity | -3.81% | -0.97% | -33.27% | -28.46% | -21.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.81% | -0.97% | -33.27% | -28.46% | -21.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.81% | -0.97% | -33.27% | -28.46% | -21.79% |
|
|
|||||